Infinity Announces the Date of its Third Quarter 2013 Financial Results
Conference Call and Webcast
CAMBRIDGE, Mass. -- October 24, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Thursday, November 7, 2013, at 4:30 p.m. ET. During the call, management will
review the company's third quarter 2013 financial results and provide an
update on Infinity's business.
A live webcast of the conference call can be accessed in the Investors/Media
section of Infinity's website at www.infi.com. To participate in the
conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526
(international) five minutes prior to start time. The conference ID number is
34959052. An archived version of the webcast will be available on Infinity's
website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. For more information on Infinity, please refer to the
company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Jaren Madden, 617-453-1336
Press spacebar to pause and continue. Press esc to stop.